logo
Plus   Neg
Share
Email

Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen

Thermo Fisher Scientific Inc. (TMO), the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV (QGEN,QGENF), Bloomberg reported citing people familiar with the matter.

The Dutch company Qiagen, which is listed in New York and Frankfurt, has a market value of about $8 billion as of Wednesday's close.

There's no certainty the discussion will lead to a deal, and other bidders for Qiagen could emerge, the report said.

QGEN closed Wednesday regular trading at $35.45, up $3.19 or 9.89 percent. In the after-hours, the stock further gained $0.70 or 1.97 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT